Simplified Chinese

English

Home page

Beijing Minhai Biotechnology Co., Ltd. Public Notice on the Phased Completion Environmental Protection Acceptance for the “Minhai Biotechnology New‑Type Vaccine Internationalization Industrial Base (Phase I) Construction Project”

Release date:

2024-10-14

Author:

Source:

Abstract

In accordance with the “Decision of the State Council on Amending the Regulations on Environmental Protection Management of Construction Projects” (State Council Order No. 682) and the “Notice on the Issuance of the Interim Measures for Environmental Protection Acceptance upon Completion of Construction Projects” (Guohuan Gui Huanping [2017] No. 4), the “Environmental Protection Acceptance Report upon Completion (Phase I) for the Minhai Biotechnology International Vaccine Industrial Base Project” is hereby made public as follows: Project Name: Construction of the Minhai Biotechnology International Vaccine Industrial Base (Phase I) Project Undertaker: Beijing Minhai Biotechnology Co., Ltd. Publicized Contents: The environmental protection acceptance report upon completion, along with any other matters requiring clarification.

Pursuant to the “State Council Decision on Amending” < Regulations on the Environmental Protection Management of Construction Projects > Decision of the State Council No. 682 Order), as well as “Regarding the Issuance of” < Interim Measures for Environmental Protection Acceptance upon Completion of Construction Projects > Announcement (National Environmental Impact Assessment Regulations) [2017]4 No.), we hereby announce the “ Environmental Protection Acceptance Report for the Completion of the Phase I Construction Project of Minhai Biotechnology’s International Vaccine Industrial Base 》The public notice is as follows:

Project Name: Minhai Biotechnology’s Internationalization Industrial Base for Novel Vaccines (Phase I) Construction Project

Construction Unit: Beijing Minhai Biotechnology Co., Ltd.

Public notice content: Completion environmental protection acceptance report, other matters requiring clarification, and acceptance opinions (see link: https://pan.baidu.com/s/1p8CirOkEn7i2Eff_kpOKig; extraction code: y2q5). )

Public Notice Period: 2024 year 10 month 14 Effective date 20 working days

Public Notice Period: Any objections to the above‑mentioned content should be submitted in writing. Individuals must provide their real names, and organizations must affix their official seal.

Contact phone number: 010-59613634

Keywords:

Public Notice Regarding the Recommendation of Nie Xiaoqi for the “2025 Beijing Model Worker” Selection

Public Disclosure Prior to Approval of the Environmental Impact Report for the Nucleic Acid Vaccine R&D and Pilot-Scale Production Project

Recommended Reading

Batch Release Status of the Company’s Products in 2026

The company's product 2026 annual batch issuance situation is as follows:

2026-07-23

Good News | Another Star Award! Minhai Biotechnology has once again been recognized as a “Five-Star Green Credit Enterprise” in Daxing District.

Recently, the Daxing District Bureau of Ecology and Environment completed the fifth round of corporate green credit rating for 2025 and officially released the “2025 Daxing District Green Credit Enterprise Directory.” Thanks to its robust environmental management system, consistent compliance performance, and outstanding achievements in energy conservation and carbon reduction, Minhai Biotechnology has once again been awarded the region’s highest “Five-Star Green Credit Enterprise” rating. The Daxing District’s corporate green credit assessment covers five major categories—environmental compliance, pollution control and emission reduction, low‑carbon circular economy, scientific management, and social contribution—comprising a total of 30 sub‑indicators. With stringent standards and comprehensive evaluation, the program employs dynamic review and a veto‑based mechanism, with the Five‑Star rating representing the highest level of ecological credit in the district.

2026-07-15

Good News | The Party Branch of Minhai Biotechnology has been awarded the “Two Excellences and One Pioneer” honor in Beijing’s emerging sectors, as well as a park‑level commendation.

Recently, Beijing held a grand commendation conference for the “Two Excellences and One Pioneer” initiative in emerging sectors. The “Two New” Working Committee of the CPC Beijing Municipal Committee recognized outstanding Communist Party members, exemplary Party affairs workers, and advanced primary-level Party organizations across the city’s emerging fields. The Party branch of Beijing Minhai Biotechnology Co., Ltd. was honored as an advanced primary-level Party organization in Beijing’s emerging sectors. Wu Chengyu, the branch secretary, attended the ceremony in person to receive the award. At the event, the Party flag flew proudly amid a solemn atmosphere, and the awardees, adorned with honor ribbons and holding certificates and medals, jointly witnessed this prestigious municipal recognition. This designation as an advanced primary-level Party organization at the municipal level represents the “Two New” Working Committee of the Municipal Party Committee’s high appraisal of the Minhai Biotechnology Party branch.

2026-07-09

Online Customer Service

Telephone

400 189 9806

Contact Information

Customer Service Hotline

4001899806

Phone number

010-59613600

Official Website

http://www.biominhai.com

Company Address

No. 35 Simiao Road and No. 25 Tianfu Street, Daxing Biomedical Industry Base, Zhongguancun Science Park, Daxing District, Beijing

WeChat Official Account

Business license

Website Development: China Enterprise Dynamics

Beijing

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.